January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The antibody optimization service market was valued at USD 2.77 billion in 2024 and is projected to reach USD 6.07 billion by 2034, growing at a CAGR of 8.45%. The report covers technology segments (CRISPR, TALEN, ZFN) and applications (therapeutics, biotechnology). Asia-Pacific is the fastest-growing region among NA, EU, APAC, LA, and MEA due to r...
April 21, 2026
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights, and revenue forecasts. North America holds 35% share, APAC grows fastest (China, India), and Europe...
April 21, 2026
The globe is emphasizing the reduction of hypoglycemia risk is fueling the global demand. North America’s growing type 2 DM instances fueled its dominance....
April 21, 2026
The market is experiencing strong growth due to the rising demand for molecular diagnostics, increasing genomic research, and advancements in personalized medicine. North America dominated the market, supported by its advanced healthcare infrastructure, growing investments in biotechnology, and early adoption of innovative diagnostic technologies....
April 21, 2026
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advantages, such as low manufacturing cost, reduced contamination, and a simpler manufacturing process tha...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives the global market. North America dominated the global market due to the presence of key players and...
April 21, 2026
Market insights predict, the human biofluid collection services industry is expected to grow from USD 1.48 billion in 2024 to USD 2.93 billion by 2034, driven by a CAGR of 7.08%. The notable importance of biofluids in clinical diagnostics and biomedical research drives the global market. North America dominated the market in 2024, led by minimally ...
April 21, 2026
Based on market forecasts, the multiplex PCR kit sector will expand from USD 1.25 billion in 2024 to USD 3.43 billion by 2034, experiencing a CAGR of 10.64%. The Multiplex PCR Kit Market is growing due to its significant applications in diagnosing infections, genetic analysis, forensic science, food safety, and veterinary medicine. North America is...
April 21, 2026
The seasonal vaccines market is expanding due to growing government initiatives as well as rising post-pandemic awareness. North America led the market due to the high healthcare investments....
April 21, 2026
Market insights predict, the cell culture collagen industry is expected to grow from USD 2.31 billion in 2024 to USD 4.19 billion by 2034, driven by a CAGR of 6.15%. The Cell Culture Collagen Market is growing due to rising demand for cell and gene therapies and advancements in regenerative medicine. North America is dominant in the market due to...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com